BIO-TECHNE CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 77.29 USD | +2.24% |
|
+20.65% | +0.17% |
| May. 02 | UBS Adjusts Price Target on Bio-Techne to $90 From $80, Maintains Buy Rating | MT |
| May. 02 | Leerink Partners Adjusts Price Target on Bio-Techne to $95 From $85 | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- TECH Stock
- Revisions Bio-Techne Corporation
